Home/Filings/4/0001209191-21-036939
4//SEC Filing

TANG CAPITAL PARTNERS LP 4

Accession 0001209191-21-036939

CIK 0000920465other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 6:42 PM ET

Size

16.1 KB

Accession

0001209191-21-036939

Insider Transaction Report

Form 4
Period: 2021-05-27
TANG KEVIN C
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2021-06-01$4.53/sh+43,734$198,01410,049,224 total(indirect: By LP)
  • Purchase

    Common Stock

    2021-05-27$4.47/sh+184,642$825,9789,990,132 total(indirect: By LP)
  • Purchase

    Common Stock

    2021-06-01$4.29/sh+15,358$65,91710,005,490 total(indirect: By LP)
  • Purchase

    Common Stock

    2021-05-27$4.50/sh+1,286$5,7859,805,490 total(indirect: By LP)
Footnotes (5)
  • [F1]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $4.49 to $4.50. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 through 5 herein.
  • [F2]The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Michael Hearne is the Chief Financial Officer of La Jolla Pharmaceutical Company, as well as Chief Financial Officer of TCM. Mr. Tang and Mr. Hearne each have a pecuniary interest in the shares beneficially held by TCP.
  • [F3]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $4.40 to $4.50.
  • [F4]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.37.
  • [F5]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $4.35 to $4.65.

Issuer

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001191935

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 6:42 PM ET
Size
16.1 KB